Skip to main content
. 2012 Dec 15;17(12):1714–1727. doi: 10.1089/ars.2012.4639

Table 1.

Mitochondrial Thiols and Related Enzymatic Systems in Disease

  Thiols involved References
Neurodegeneration
 Models of Alzheimer's disease Prx3, GSH 16, 55, 91
 Models of Parkinson's disease Grx1*, Grx2, GSH, Protein-SSG, Prx3, Prx5 27, 44, 55, 60, 94, 98, 125, 155
 Excitotoxicity Prx3 60
 Down syndrome Prx3 91, 94
Liver diseases
 Alcohol-induced hepatoxicity Srx 9
 Alcoholic steatohepatitis GSH 33, 105, 201, 202
 Nonalcoholic steatohepatitis GSH 109
 Chronic alcoholism GSH 50
 Acetaminophen toxicity GSH 179, 201
 Liver cirrhosis GSH 93
Cardiovascular diseases
 Ischemic preconditioning Protein-SSG, Protein-SNO 24, 62
 Dilated cardiomyopathy TrxR2 160
 Myocardial infarction Prx3 7
 Vascular muscle function Protein-SSG 63
Diabetes
 Glucose tolerance Prx3 21
 Diabetic retinopathy GSH 86
Cancer
 Hepatocellular carcinomas TrxR2, Prx3 29
 Human breast cancer Prx3 129
 Colon cancer cell protection Prx3 131
 Neoplastic transformation Prx3 188
Aging GSH, Prx5 43, 146, 165, 181
Stroke - Focal cerebral ischemia GSH 3, 163

The table summarizes the involvement of selective mitochondrial thiols in different disease models addressed in this review. *Glutaredoxin-1 in the inter-membrane space.